At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Anstellungsbehörde / Dienststelle / Anstalt Die Volkswirtschafts- und Berufsbildungsdirektion VWBD ist zuständig für die Wirtschaftsförderung im Kanton. Sie hat die Aufgabe, die wirtschaftliche Dynamik, einschliesslich des Tourismus, zu stimulieren. Sie fördert die Energieeffizienz und die erneuerbaren
À propos du poste Nous recherchons un Spécialiste systèmes de conduite autonome (Self-Driving Systems Specialist / SDS Specialist) pour soutenir le diagnostic, la calibration, la configuration et la préparation technique des self-driving systems utilisés dans les
À propos du poste Nous recherchons des Techniciens seniors véhicules autonomes pour soutenir la maintenance, le diagnostic, la réparation et la préparation opérationnelle de flottes de véhicules autonomes et d’opérations robotaxi en Europe. En tant que
À propos du poste Nous recherchons des Spécialistes Dépôt pour soutenir les opérations quotidiennes de flottes de véhicules autonomes (AV) et de robotaxis en Europe. En tant que Spécialiste Dépôt, vous jouerez un rôle clé pour
À propos du poste Nous recherchons des Opérateurs de sécurité véhicule autonome (Autonomous Vehicle Safety Operators / Safety Drivers) pour soutenir les tests, la validation, le déploiement commercial et la montée en charge de flottes de
Work Flexibility: Hybrid Job Title: RAQA Specialist (m/f/d) – Regulatory Affairs & Quality Systems Job Summary: As a RAQA Specialist, you will support Regulatory Affairs and Quality activities for our business across Germany, Switzerland, and Austria
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Life. Unlimited. At Smith+Nephew we design and manufacture technology that takes the limits off living. We are currently searching for a Regulatory Affairs Specialist who will support with global registration and maintenance of submission of medical
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Bedrijfsomschrijving Leid jouw team naar succes, bepaal de controle strategie en controleer de jaarrekeningen voor toonaangevende bedrijven. Bij Deloitte. Vacatureomschrijving opstellen van het dienstverleningsplan voor de klant, samen met de Partners en Managers; identificeren van probleemgebieden
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Unternehmensbeschreibung medmix ist ein weltweit führender Anbieter von hochpräzisen Verabreichungsgeräten. Wir nehmen führende Positionen in den Endmärkten Gesundheitswesen, Verbraucher und Industrie ein. Unsere Kunden profitieren von unserem Engagement für Innovation und technologischen Fortschritt, das sich in
Join Our Team and Drive Clinical Research Success! At Fortrea, we are committed to accelerating clinical trials and ensuring regulatory compliance. As a Site Start-Up Specialist (location: Switzerland, Home-based), you will play a pivotal role in
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
The opportunity: Being part of HSBC in Switzerland, you’ll help evolve and grow our business. The Front Office Customer Due Diligence Advisor is responsible for championing end-to-end CDD activity across onboarding and the client lifecycle, driving